Adamas Pharmaceuticals Inc (25) | Purchase Agreements (2)
- First Amendment to Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC (Filed With SEC on August 9, 2021)
- Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC (Filed With SEC on February 23, 2021)
